Monday 25th November 2019
10:00–13:00
Charles Sultan 
Adolescence: a high risk period for PCOS development?
Alessandro Genazzani 
Neuroendocrine and metabolic impairments
Ruben Heremans 
Sonographic 2D and 3D idiosyncrasies of the polycystic ovary
10:00–13:00
Charles Sultan Adolescence: a high risk period for PCOS development?
Adolescence: a high risk period for PCOS development?
Alessandro Genazzani Neuroendocrine and metabolic impairments
Neuroendocrine and metabolic impairments
Ruben Heremans Sonographic 2D and 3D idiosyncrasies of the polycystic ovary
Sonographic 2D and 3D idiosyncrasies of the polycystic ovary
13:00-14:00 Light lunch
14:00-15:00 Clinical case with the expert
Frederic Chantraine Clinical case of AIP (abnormally invasive placenta)
Clinical case of AIP (abnormally invasive placenta)
Bart Fauser
Teatment of anovulatory infertility
Teatment of anovulatory infertility
Alessandro Genazzani Hyperandrogenic amenorrhea: from diagnosis to treatment
Hyperandrogenic amenorrhea: from diagnosis to treatment
Andrea Genazzani The woman over 40
The woman over 40
Ruben Heremans Polycystic ovarian morphology in young patients
Polycystic ovarian morphology in young patients
Michelle Nisolle Hysteroscopy in AUB
Hysteroscopy in AUB
John Stevenson 
Insulin resistance
Insulin resistance
Charles Sultan Adolescent hirsutism = management
Adolescent hirsutism = management
Basil Tarlatzis 
Diagnostic Criteria of PCOS
Diagnostic Criteria of PCOS
15:15–18:15
Basil Tarlatzis Treatment of Infertility in women with PCOS
Treatment of Infertility in women with PCOS
Rossella Nappi Quality of life and Sexual Health
Quality of life and Sexual Health
Bart Fauser PCOS: implications for reproduction and beyond
PCOS: implications for reproduction and beyond
Tuesday 26th November 2019
08:30–13:00
Andrzej Milewicz 
Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome
Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome
John Stevenson Cardiovascular impact of metabolic abnormalities
Cardiovascular impact of metabolic abnormalities
Andrea Genazzani Personalized therapies: why, when and for how long, the need of tailoring
Personalized therapies: why, when and for how long, the need of tailoring
Frederic Chantraine PCO and pregnant: what the physician (or obstetrician) has to know to assure the best pregnancy follow-up
PCO and pregnant: what the physician (or obstetrician) has to know to assure the best pregnancy follow-up
13:00-14:00 Light lunch
14:00-15:00 Clinical case with the expert
Frederic Chantraine Additive value of sFlt-1/PlGF in preeclampsia
Additive value of sFlt-1/PlGF in preeclampsia
Bart Fauser Ovarian stimulation for IVF
Ovarian stimulation for IVF
Alessandro Genazzani Weight loss amenorrhea: how to evaluate the exams to better choose the therapeutic strategy
Weight loss amenorrhea: how to evaluate the exams to better choose the therapeutic strategy
Andrea Genazzani After deliveries and between pregnancies: How to manage
After deliveries and between pregnancies: How to manage
Ruben Heremans The multifollicular versus the polycystic ovary
The multifollicular versus the polycystic ovary
Andrzej Milewicz Vitamin D and metabolic and hormonal disorders in PCOS
Vitamin D and metabolic and hormonal disorders in PCOS
Michelle Nisolle Infertility management in PCO patients
Infertility management in PCO patients
Tommaso Simoncini Managing perimenopausal symptoms in women at increased cardiometabolic risk
Managing perimenopausal symptoms in women at increased cardiometabolic risk
John Stevenson Dyslipidaemia
Dyslipidaemia
15:15–17:15
Michelle Nisolle How to prevent, to diagnose and to treat gynecological cancer in PCO patients?
How to prevent, to diagnose and to treat gynecological cancer in PCO patients?
Tommaso Simoncini Metabolic changes at the menopausal transition
Metabolic changes at the menopausal transition
17:15–17:30 Closing remarks